RSV vaccine coverage report in older adults for catch-up cohorts in England: February 2025
Updated 25 March 2025
Applies to England
© Crown copyright 2025
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/rsv-immunisation-for-older-adults-and-pregnant-women-vaccine-coverage-in-england/rsv-vaccine-coverage-report-in-older-adults-for-catch-up-cohorts-in-england-february-2025
Main points
The Respiratory Syncytial Virus (RSV) vaccination programme was introduced in September 2024. The routine programme offers the vaccine to those turning 75 and patients remain eligible for the vaccine until their 80th birthday (Table 1).
This report evaluates vaccine coverage in the catch-up cohorts aged 75 to 79 years old before 1 September 2024 and until 31 August 2025, assessed at the end of February 2025.
The key conclusions are that, as of 28 February 2025:
the overall vaccine coverage in the catch-up cohort (adults aged 75 to 79 before the programme start date) reached 54.8%, up from the 50.8% reported in the January 2025 report (1)
coverage in the most deprived decile was 42.0% and in the least deprived decile was 63.0% (Table 4)
Analysis
The RSV vaccination programme for the older adults catch-up cohorts aged 75 to 79 before 1 September 2024 achieved a cumulative coverage rate of 54.8% (Table 1)(Figure 1).
Across the catch-up cohorts, the coverage by region, ethnicity, sex and deprivation deciles was as follows:
- regional vaccine coverage was highest in the South East (60.3%) and lowest in London (43.1%) (Table 2)
- coverage varied by ethnic group and the highest coverage was reported among White – British (57.8%) and the lowest among Asian or Asian British – Pakistani (18.7%) (Table 3)
- coverage in males was 56.9% and in females was 53.0%
Table 1. Cumulative RSV vaccine coverage for older adults in the catch-up cohorts, measured at 28 February 2025
| Cohort group | Birth range of cohort | Age turned in September 2024 | Cumulative RSV coverage (%) |
|---|---|---|---|
| Catch-up cohort 1 | 1 September 1948 to 31 August 1949 | 75 | 53.7 |
| Catch-up cohort 2 | 1 September 1947 to 31 August 1948 | 76 | 54.2 |
| Catch-up cohort 3 | 1 September 1946 to 31 August 1947 | 77 | 55.2 |
| Catch-up cohort 4 | 1 September 1945 to 31 August 1946 | 78 | 55.3 |
| Catch-up cohort 5 | 1 September 1944 to 31 August 1945 | 79 | 56.1 |
| Total (Catch-up cohort) | 54.8 |
Figure 1. Cumulative RSV vaccine coverage for older adults catch-up cohorts, measured at 28 February 2025
Table 2. RSV vaccine coverage for older adults in the catch-up cohorts, measured at 28 February 2025, by commissioning region
| Commissioning region | RSV coverage (%) |
|---|---|
| London | 43.1 |
| North West | 50.7 |
| Midlands | 53.7 |
| South West | 56.6 |
| North East and Yorkshire | 57.1 |
| East of England | 57.6 |
| South East | 60.3 |
Table 3. RSV vaccine coverage for older adults in the catch-up cohorts, measured at 28 February 2025, by ethnicity
| Ethnic group | RSV coverage (%) |
|---|---|
| Asian or Asian British – Pakistani | 18.7 |
| Asian or Asian British – Bangladeshi | 21.2 |
| Black or Black British – African | 22.2 |
| Black or Black British – Caribbean | 22.5 |
| Black or Black British – Any other Black background | 25.1 |
| Mixed – White and Black African | 30.8 |
| Mixed – White and Black Caribbean | 31.5 |
| Asian or Asian British – Any other Asian background | 34.8 |
| Other ethnic groups – Any other ethnic group | 36.5 |
| Asian or Asian British – Indian | 36.7 |
| Other ethnic groups – Chinese | 37.8 |
| Mixed – White and Asian | 42.4 |
| Mixed – Any other mixed background | 44.3 |
| Ethnicity not stated | 45.4 |
| White – Other | 46.8 |
| White – Irish | 47.3 |
| White – British | 57.8 |
Table 4. RSV vaccine coverage for older adults in the catch-up cohorts, measured at 28 February 2025, by IMD 2019 deprivation deciles
| Deprivation deciles | RSV coverage (%) |
|---|---|
| 1 (Most deprived) | 42.0 |
| 2 | 44.7 |
| 3 | 47.5 |
| 4 | 51.1 |
| 5 | 53.7 |
| 6 | 55.7 |
| 7 | 57.0 |
| 8 | 58.7 |
| 9 | 60.4 |
| 10 (Least deprived) | 63.0 |
Discussion
Cumulative coverage in the catch-up cohorts of the RSV vaccination programme for older adults has been steadily increasing since the programme’s inception. Coverage has risen from 22.6% in September 2024 (2) to 54.8% by the end of February 2025. As the older adults remain eligible until their 80th birthday, it is expected that coverage in this cohort will increase progressively as they remain eligible for longer and have more opportunities to be vaccinated.
In addition, this report highlights that coverage varies by nearly 17.2 percentage points between regions, approximately 39.0 percentage points between ethnicities and 21.0 percentage points between the most and least deprived decile.
Background information
The RSV vaccination programme for the older adult cohorts aged 75 to 79 before 1 September 2024 achieved a cumulative coverage rate of 54.8%.
The RSV vaccination programme for the older adults was launched in England on 1 September 2024 as a single-dose vaccine for adults turning 75 years old on or after the programme start date. A catch-up programme applies to those aged over 75, at programme start, until they are 79 years of age. Those turning 80 during the first year of the programme are also eligible and will remain so until 31 August 2025.
The populations eligible for the programme are defined in the Green Book (3), as follows:
- adults turning 75 years old on or after the programme start date (1 September 2024): the routine cohort
- adults already 75 to 79 years old before the programme start date – comprising five “catch-up” cohorts – are eligible up until their 80th birthday, and
- those turning 80 in the first year of the programme will be eligible for vaccination until 31 August 2025
The primary aim is to reduce severe illness, hospitalisations, and complications resulting from RSV infections among older adults especially those over the age of 75 (4,5).
This monthly report includes vaccine coverage data up to 28 February 2025.
Data sources and methodology
This is the fifth in the series of older-adult RSV vaccination coverage reports that will be released monthly, providing cumulative vaccination uptake since the start of the campaign. The reporting period in the current report is from 1 September 2024 to 28 February 2025. Data is collected through the Immunisation Information System (IIS), which holds denominator data and captures vaccination events from GP practices and participating community pharmacies across England, based on data provided by NHS England.
The data was extracted on 4 March 2025 to include vaccinations administered up to midnight of the last day of the reporting month (28 February 2025).
The five catch-up cohorts are defined by their birth year and age as of the programme start date. A more detailed breakdown of the different cohorts can be found in Table 1.
This report focuses solely on the catch-up cohorts. The routine cohort – defined as those turning 75 since the programme’s start date – are gradually becoming eligible as the vaccination programme progresses and have not yet had sufficient time to be notified and to present to a clinic for their vaccination. Limiting this report to the catch-up cohorts avoids the risk of presenting early and potentially misleading data that underestimates uptake in the routine cohort and the eligible adult population overall. A complete assessment of coverage in the routine cohort will be available once the whole cohort has become eligible and has had the opportunity to be vaccinated.
Data extraction notes:
- Population estimates for denominator data and vaccination records were extracted from the Immunisation Information System (IIS) on 4 March 2025 for vaccine events up to 28 February 2025.
- The data for the new RSV programme relies on new data flows and is, therefore, provisional while enhanced data validation checks are being conducted. Any changes to historic figures will be reflected in the most recent publication.
The March 2025 older adult RSV vaccination coverage report is scheduled to be released on 24 April 2025.
Birth cohorts
Table 4. Birth range and RSV vaccine eligibility dates for routine and catch-up cohorts of older adult populations, measured at 28 February 2025
| Cohort group | Birth range of cohort | Age turned in September 2024 |
|---|---|---|
| Routine cohort 1 | Adults turning 75 years old on or after 1 September 2024 | 75 |
| Catch-up cohort 1 | 1 September 1948 to 31 August 1949 | 75 |
| Catch-up cohort 2 | 1 September 1947 to 31 August 1948 | 76 |
| Catch-up cohort 3 | 1 September 1946 to 31 August 1947 | 77 |
| Catch-up cohort 4 | 1 September 1945 to 31 August 1946 | 78 |
| Catch-up cohort 5 | 1 September 1944 to 31 August 1945 | 79 |
References
1. UKHSA (February 2025). ‘RSV vaccine coverage report in older adults for catch-up cohorts in England: January 2025’. Health Protection Report volume 19, issue 2
2. UKHSA (September 2024). ‘RSV vaccine: interim report on uptake of the new, older adult vaccination programme in England’. Health Protection Report volume 18, issue 9
3. UKHSA (2024). Green Book chapter 27a: Respiratory syncytial virus
4. Department of Health and Social Care (June 2024). Introduction of new NHS vaccination programmes against respiratory syncytial virus
5. UKHSA (July 2024). RSV Vaccination of older adults: information for healthcare practitioners